What is the pen needles market size in 2023?

The pen needles market size is USD 3.4 Billion in 2023.

What is the CAGR for the pen needles market?

The pen needles market is expected to grow at a CAGR of 10.9% during 2024-2033.

What are the segments covered in the pen needles market report?

Market.US has segmented the Global pen needles Market Value (US$ Mn) Analysis by Region, 2023 market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Product Type, market has been segmented into standard pen needles and safety pen needles. By Needle Length, market has been further divided into 5 mm, 6 mm, 8mm, 10 mm, and other needle length. By Therapy, market has been further divided into Insulin, Growth hormone, and Glucagon-like-Peptide-1 (GLP-1).

Who are the key players in the pen needles market?

Novo Nordisk A/S, Becton, Dickinson and Company, Terumo Corp., Owen Mumford Ltd., B. Braun Melsungen AG, HTL-STREFA, UltiMed Inc., Allison Medical Inc., Artsana S.p.A. Other Key Players are the key vendors in the Pen needles market.

Which region is more attractive for vendors in the pen needles market?

Europe is expected to account for the highest revenue share of 38.9% among the other regions and reached USD 1.4 billion for the year 2023. Therefore, the pen needles market in Europe is expected to garner significant business opportunities for the vendors during the forecast period.

What are the key markets for pen needles?

Key markets for pen needles are the U.S., Canada, the U.K., Germany, Japan, India, China, Brazil, Mexico, and South Africa.

Which segment has the largest share in the pen needles market?

In the pen needles market, vendors should focus on grabbing business opportunities from the 8 mm Needle length segment as it accounted for the largest market share in the base year.

Global Pen Needles Market Analysis By Product Type (Standard Pen Needles, Safety Pen Needles), By Needle Length (4 mm, 5 mm, 6 mm, 8 mm, 10 mm, 12 mm), By Therapy (Insulin, Glucagon-like-Peptide-1 (GLP-1), Growth Hormone) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Nov 2023
Report ID: 20487
Number of Pages: 232
Format:

- Novo Nordisk A/S Company Profile
- Becton, Dickinson and Company Profile
- Dickinson and Company
- Terumo Corp.
- Owen Mumford Ltd.
- B. Braun Melsungen AG Company Profile
- HTL-STREFA
- UltiMed Inc.
- Allison Medical Inc.
- Artsana S.p.A.
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 20487
Published Date Nov 2023
Rating
- ★★★★★
  
  ★★★★★
- (30)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)